Access & Support
Access
Help your patients get the medication they need
UCB is committed to making BRIVIACT accessible for the majority of eligible patients across the US
ABOUT
2
OUT
OF
3
patients could have
access to BRIVIACT first
This means they should not have to try and fail
other antiseizure medications, including generics,
for their insurance to cover BRIVIACT.1*
9
OUT
OF
10
commercial patients have formulary access to BRIVIACT2
*
Formularies can change and many health plans offer more than one formulary. Please check directly with the health plan to confirm coverage for individual patients.1
Savings
BRIVIACT Patient Savings Program
Eligible patients pay as little as $10 per 30-day supply of BRIVIACT†
†
Savings card is not valid for use by patients who are covered by any federally funded or state-funded healthcare program (including, but not limited to, Medicare [Part D and Medigap] and those who are Medicare eligible and enrolled in an employer-sponsored health plan for retirees, Medicaid, any state pharmaceutical assistance program, TRICARE, VA, or DoD), or for cash-paying patients. A valid BRIVIACT prescription consistent with the approved FDA labeling is required. Other eligibility criteria and terms apply. Full eligibility criteria and terms are available at www.BRIVIACT.com or upon request by calling UCBCares® at 833-948-2394.
Enhanced copay support for eligible commercial
BRIVIACT patients
UCB has expanded out-of-pocket support for BRIVIACT to help patients afford their medication
UCB is introducing enhancements to the BRIVIACT prescription savings program for eligible commercial patients
Affordable payments
Most commercially insured patients should pay as little as $10 for their BRIVIACT prescription. No copay card will be required when filling a prescription at a participating pharmacy.
Additional support with the eVoucher‡
Beginning in January 2024, more than 90% of retail pharmacies across the US will participate in the eVoucher savings program so eligible commercial patients will automatically receive out-of-pocket support at the point of adjudication.
Increased out-of-pocket support starting in 2024
UCB is increasing the maximum patient savings to $1,500 per script and $6,000 per year. Support will be available at participating pharmacies for eligible commercially insured patients.
‡
The eVoucher savings program is not for use by patients who are covered by any federally funded or state-funded healthcare program (including, but not limited to, Medicare [Part D and Medigap] and those who are Medicare eligible and enrolled in an employer-sponsored health plan for retirees, Medicaid, any state pharmaceutical assistance program, TRICARE, VA, or DoD), or for cash-paying patients. Offer good only in the US, including Puerto Rico.
The eVoucher savings program may only be used with a valid BRIVIACT prescription consistent with the approved FDA labeling at the time the prescription is filled by the pharmacist and dispensed to the patient. The maximum annual benefit amount is $6,000 per calendar year. Void where prohibited by law, taxed, or restricted. This offer cannot be combined with any other promotional offer. UCB, Inc. reserves the right to rescind, revoke, or amend this offer without notice at any time. No cash value. Not eligible for sale, purchase, trade, or counterfeit.
Assistance
Helping eligible patients start on BRIVIACT
New patients may be eligible for a FREE trial voucher with a 14-day prescription
Contact your UCB representative to receive a patient voucher for a 14-day supply of BRIVIACT.
The BRIVIACT Patient Assistance Program may be able to help if your patients do not have health insurance or otherwise cannot afford BRIVIACT.
To learn more about the BRIVIACT Patient Assistance Program and check eligibility:
Call
Enroll Online
References: 1. Managed Markets Insight & Technology, LLC, database as of August 2021. 2. Data on file. UCB, Inc.